Patent "Evergreening" of Medicine-Device Combination Products: A Global Perspective.

导出 OA

翻译打印收藏纠错

作者： Reed F,Beall ^[1] ; Tali,Glazer ^[2] ; Haris,Ahmad ^[2] ; Mikayla,Buell ^[2] ; Slane,Hahn ^[2] ; Adam R,Houston ^[3] ; Aaron S,Kesselheim ^[4] ; Jason W,Nickerson ^[5] ; Warren,Kaplan ^[6]

作者单位： Assistant Professor, Department of Community Health Sciences, Cummings School of Medicine, University of Calgary, Calgary, AB. ^[1] Research Assistant, Department of Community Health Sciences, Cummings School of Medicine, University of Calgary, Calgary, AB. ^[2] Centre for Health Law, Policy and Ethics, Faculty of Law, University of Ottawa, Ottawa, ON. ^[3] Professor, Program On Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. ^[4] Adjunct Professor, Centre for Health Law, Policy and Ethics, Faculty of Law, University of Ottawa, Clinical Investigator, Bruyère Research Institute, Ottawa, ON. ^[5] Clinical Assistant Professor, School of Public Health, Boston University, Boston, MA. ^[6]

主题词人类(Humans);药用制剂(Pharmaceutical Preparations);加拿大(Canada)

DOI 10.12927/hcpol.2022.26973

PMID 36495532

发布时间 2023-11-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交